Tuesday November 24 2009 | Biotechnology feed | All feeds

News Articles on Datamonitor

Sankyo and Daiichi plans show Japanese consolidation goes on

http://www.bioportfolio.com/news/Sankyo_and_Daiichi_plans_show_Japanese.html - Saturday October 1 2005

Western invasion threatens Japanese pharma's survival

http://www.bioportfolio.com/news/Western_invasion_threatens_Japanese_pharma%27s.html - Saturday October 1 2005

The FDA has requested a label change for AstraZeneca's Iressa, to be

http://www.bioportfolio.com/news/The_FDA_has_requested_a_label_change_for.html - Thursday September 1 2005

Daxas deal leaves Altana short of breath

http://www.bioportfolio.com/news/Daxas_deal_leaves_Altana_short_of_breath.html - Thursday September 1 2005

Merck & Co - Amrad: an uncertain pathway to success

http://www.bioportfolio.com/news/Merck_%26amp%3B_Co_-_Amrad%3A_an_uncertain_pathway_to.html - Friday July 1 2005

Drug Safety in the Post-Vioxx Era

http://www.bioportfolio.com/news/Drug_Safety_in_the_Post-Vioxx_Era.html - Friday July 1 2005

Capravirine discontinued, but Pfizer's HIV R&D won't stop

http://www.bioportfolio.com/news/Capravirine_discontinued%2C_but_Pfizer%27s_HIV.html - Wednesday June 1 2005

New beginnings for brain cancer treatment

http://www.bioportfolio.com/news/New_beginnings_for_brain_cancer_treatment.html - Wednesday June 1 2005

Eyes turning to Neuropathic pain market

http://www.bioportfolio.com/news/Eyes_turning_to_Neuropathic_pain_market.html - Wednesday June 1 2005

The Pharmaceutical Market Outlook to 2015 Implementing innovative,

http://www.bioportfolio.com/news/The_Pharmaceutical_Market_Outlook_to_2015.html - Sunday May 1 2005

Cytotoxics remain standard bearers

http://www.bioportfolio.com/news/Cytotoxics_remain_standard_bearers.html - Sunday May 1 2005

Big pharma set to move into HIV/hepatitis co-infection niche

http://www.bioportfolio.com/news/Big_pharma_set_to_move_into_HIV%2Fhepatitis.html - Tuesday March 1 2005

Chronic viral hepatitis: B is for billions

http://www.bioportfolio.com/news/Chronic_viral_hepatitis%3A_B_is_for_billions.html - Tuesday March 1 2005

Gilead initiates trial to evaluate HIV drug

http://www.bioportfolio.com/news/Gilead_initiates_trial_to_evaluate_HIV_drug.html - Tuesday March 1 2005

HIV vaccines: education key to partial efficacy success

http://www.bioportfolio.com/news/HIV_vaccines%3A_education_key_to_partial_efficacy.html - Wednesday December 1 2004

Aventis and Sanofi: Merger speculation continues

http://www.bioportfolio.com/news/Aventis_and_Sanofi%3A_Merger_speculation_continues.html - Wednesday December 1 2004

Marburg outbreak raises tropical disease profile

http://www.bioportfolio.com/news/Marburg_outbreak_raises_tropical_disease_profile.html - Friday October 1 2004

The Cardiovascular Market Outlook to 2009

http://www.bioportfolio.com/news/The_Cardiovascular_Market_Outlook_to_2009.html - Friday October 1 2004

New Survey forecasts over 70% revenue growth in systematic antifungal

http://www.bioportfolio.com/news/New_Survey_forecasts_over_70%25_revenue_growth_in.html - Thursday July 1 2004

Pharmaceutical Portfolio Management: Integrated decision-making

http://www.bioportfolio.com/news/Pharmaceutical_Portfolio_Management%3A_Integrated.html - Tuesday June 1 2004

Promising Antegren data ruffles Serono

http://www.bioportfolio.com/news/Promising_Antegren_data_ruffles_Serono.html - Saturday May 1 2004

Novel combinations breathe life into COPD market

http://www.bioportfolio.com/news/Novel_combinations_breathe_life_into_COPD_market.html - Saturday May 1 2004

Takeda makes strategic investment in Lectus Therapeutics

http://www.bioportfolio.com/news/Takeda_makes_strategic_investment_in_Lectus.html - Saturday May 1 2004

Increased HIV survival rates generate upcoming treatment challenges

http://www.bioportfolio.com/news/Increased_HIV_survival_rates_generate_upcoming.html - Saturday May 1 2004

Arava: the 'sixth drug' that may soon be under fire

http://www.bioportfolio.com/news/Arava%3A_the_%27sixth_drug%27_that_may_soon_be_under.html - Thursday April 1 2004

Isotechnika's search for a partner continues

http://www.bioportfolio.com/news/Isotechnika%27s_search_for_a_partner_continues.html - Thursday April 1 2004

Blockbuster brands generate generic goals

http://www.bioportfolio.com/news/Blockbuster_brands_generate_generic_goals.html - Sunday February 1 2004

Fluoroquinolone use set to increase, despite resistance warnings

http://www.bioportfolio.com/news/Fluoroquinolone_use_set_to_increase%2C_despite.html - Thursday January 1 2004

Omnitrope deferral casts doubt over biogeneric development

http://www.bioportfolio.com/news/Omnitrope_deferral_casts_doubt_over_biogeneric.html - Saturday November 1 2003

Life after Vioxx - $2.5 billion up for grabs?

http://www.bioportfolio.com/news/Life_after_Vioxx_-_%242.5_billion_up_for_grabs%3F.html - Saturday November 1 2003

Double trouble hits Altana respiratory pipeline

http://www.bioportfolio.com/news/Double_trouble_hits_Altana_respiratory_pipeline.html - Wednesday October 1 2003

Serevent warning focuses attention on the need for combination therapy

http://www.bioportfolio.com/news/Serevent_warning_focuses_attention_on_the_need.html - Friday August 1 2003

Japanese pharmaceutical companies: Survival through improved R&D

http://www.bioportfolio.com/news/Japanese_pharmaceutical_companies%3A_Survival.html - Friday August 1 2003

Food Allergies: Drug makers set to capitalize?

http://www.bioportfolio.com/news/Food_Allergies%3A_Drug_makers_set_to_capitalize%3F.html - Tuesday July 1 2003

It's not just drug discovery that's an expensive business

http://www.bioportfolio.com/news/It%27s_not_just_drug_discovery_that%27s_an_expensive.html - Tuesday July 1 2003

UPDATE - It's not just drug discovery that's an expensive business

http://www.bioportfolio.com/news/UPDATE_-_It%27s_not_just_drug_discovery_that%27s_an.html - Tuesday July 1 2003

Respiratory Syncytial Virus: Can antivirals make the grade?

http://www.bioportfolio.com/news/Respiratory_Syncytial_Virus%3A_Can_antivirals_make.html - Sunday June 1 2003

Biogenerics market presents new commercial opportunity

http://www.bioportfolio.com/news/Biogenerics_market_presents_new_commercial.html - Sunday June 1 2003

Flu season begins but a vaccine shortage awaits

http://www.bioportfolio.com/news/Flu_season_begins_but_a_vaccine_shortage_awaits.html - Sunday June 1 2003

CATALYST: Roche is finding it difficult to manufacture its novel

http://www.bioportfolio.com/news/CATALYST%3A_Roche_is_finding_it_difficult_to.html - Saturday March 1 2003

Serzone: New safety concerns ensures continued focus on antidepressants

http://www.bioportfolio.com/news/Serzone%3A_New_safety_concerns_ensures_continued.html - Saturday March 1 2003

Roche's Fuzeon offers hope...to the 20% of patients that receive it

http://www.bioportfolio.com/news/Roche%27s_Fuzeon_offers_hope...to_the_20%25_of.html - Saturday March 1 2003

Cancer the generic impact

http://www.bioportfolio.com/news/Cancer_the_generic_impact.html - Saturday February 1 2003

Rheumatoid Arthritis: Abbott looking for a greater share

http://www.bioportfolio.com/news/Rheumatoid_Arthritis%3A_Abbott_looking_for_a.html - Sunday December 1 2002

Multiple Myeloma: Increasing the therapeutic options

http://www.bioportfolio.com/news/Multiple_Myeloma%3A_Increasing_the_therapeutic.html - Sunday December 1 2002

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.